Sort
261,768 grants matching “gene therapy”
Clinical studies of skeletal diseases
$1,399,199Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2013 · DE
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
$1,399,048Krista H Vandenborne · University Of Florida · R01 · FY2010 · AR
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
$1,398,785Linda C Giudice · University Of California, San Francisco · P01 · FY2022 · HD
Interdisciplinary Investigation of Biological Signatures of Autism Subtypes
$1,398,688David G Amaral · University Of California At Davis · R01 · FY2010 · MH
A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
$1,398,552Xiaomin Fan · Avantgen, Inc. · R44 · FY2024 · CA
Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center
$1,398,548Richard J Samulski · Univ Of North Carolina Chapel Hill · U54 · FY2011 · AR
Clinical Trials of Patients with AIDS-Related Malignancies
$1,398,422Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Mechanisms of Fate Choice in Neural Stem Cells
$1,398,357Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2006 · NS
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
$1,398,235Bruce M Psaty · University Of Washington · R01 · FY2011 · HL
Malaria Parasite Development, Drug Resistance, Pathogenesis, and Genomics
$1,398,094Xinzhuan Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
VIRAL INFECTION INFLUENCE ON TRANSPLANTATION TOLERANCE
$1,397,788Aldo A Rossini · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · AI
Molecular and cellular mechanisms of the FVIII immune response
$1,397,646Rodney M Camire · Children'S Hosp Of Philadelphia · U54 · FY2019 · HL
Genomic Architecture of Progression and Treatment Response in AMD
$1,397,526Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2012 · EY
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS
$1,397,036Scott Powers · Cold Spring Harbor Laboratory · U01 · FY2014 · CA
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
$1,396,970Phillip A Sharp · Massachusetts Institute Of Technology · P01 · FY2014 · CA
Characterization of human hematopoietic and endodermal progenitors derived from i
$1,396,542Darrell N. Kotton · Boston University Medical Campus · RC2 · FY2009 · HL
Characterization of the Osteosarcoma Genome
$1,396,500Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,396,406Meenakshi Anurag · Baylor College Of Medicine · U01 · FY2021 · CA
Understanding Asthma Endotypes
$1,396,298David J Erle · University Of California, San Francisco · U19 · FY2021 · AI
GENE THERAPY FOR CYSTIC FIBROSIS LUNG DISEASE
$1,396,238University Of Iowa · P01 · FY2001 · HL
Research Project I: AAV-CRISPR to Treat Huntington's Disease
$1,396,185Russell Lonser · University Of California Berkeley · U19 · FY2024 · NS
Molecular and cellular mechanisms of the FVIII immune response
$1,396,051Valder R Arruda · Children'S Hosp Of Philadelphia · U54 · FY2021 · HL
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,395,721Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
DNA VIRUS AS VECTORS FOR CARDIOVASCULAR DISEASES
$1,395,686University Of Pennsylvania · P01 · FY2003 · HL
Genetics and Molecular Biology of Parkinsonism
$1,395,652Dennis William Dickson · Mayo Clinic Jacksonville · P50 · FY2013 · NS